Virtus ETF Advisers LLC Immuno Gen, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$14.09 - $19.87 $31,251 - $44,071	-2,218 Reduced 11.44%	17,174 $272,000
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $150,678 - $805,629	-40,181 Reduced 67.45%	19,392 $365,000
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $3,860 - $5,175	1,052 Added 1.8%	59,573 $228,000
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $119,119 - $165,195	26,180 Added 80.95%	58,521 $290,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $1,052 - $1,520	235 Added 0.73%	32,341 $155,000
Q2 2022 Aug 12, 2022	BUY	$3.15 - $5.76 $22,869 - $41,817	7,260 Added 29.22%	32,106 $144,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $6,292 - $11,047	-1,477 Reduced 5.61%	24,846 $118,000
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $28,162 - $44,467	-5,929 Reduced 18.38%	26,323 $195,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $8,488 - $11,143	-1,691 Reduced 4.98%	32,252 $183,000
Q2 2021 Aug 10, 2021	SELL	$5.79 - $8.6 $42,938 - $63,777	-7,416 Reduced 17.93%	33,943 $224,000
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $4,706 - $7,623	724 Added 1.78%	41,359 $335,000
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $109,438 - $226,567	-29,578 Reduced 42.13%	40,635 $262,000
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $33,057 - $46,855	-9,582 Reduced 12.01%	70,213 $253,000
Q2 2020 Aug 05, 2020	SELL	$3.32 - $5.34 $68,511 - $110,196	-20,636 Reduced 20.55%	79,795 $367,000
Q1 2020 May 14, 2020	SELL	$2.12 - $6.8 $31,045 - $99,579	-14,644 Reduced 12.73%	100,431 $342,000
Q4 2019 Feb 13, 2020	SELL	$2.25 - $5.8 $28,172 - $72,621	-12,521 Reduced 9.81%	115,075 $587,000
Q3 2019 Nov 12, 2019	SELL	$2.22 - $3.39 $15,779 - $24,096	-7,108 Reduced 5.28%	127,596 $309,000
Q2 2019 Aug 13, 2019	BUY	$1.8 - $3.3 $152,386 - $279,374	84,659 Added 169.17%	134,704 $292,000
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $16,450 - $40,341	-6,826 Reduced 12.0%	50,045 $136,000
Q4 2018 Feb 05, 2019	BUY	$3.94 - $9.7 $46,330 - $114,062	11,759 Added 26.07%	56,871 $273,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $277,375 - $363,168	-32,253 Reduced 41.69%	45,112 $427,000
Q2 2018 Aug 10, 2018	SELL	$9.52 - $12.15 $334,932 - $427,461	-35,182 Reduced 31.26%	77,365 $753,000
Q1 2018 May 14, 2018	BUY	$6.7 - $12.95 $392,419 - $758,481	58,570 Added 108.51%	112,547 $1.18 Million
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $81,414 - $127,179	-16,058 Reduced 22.93%	53,977 $346,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $34,592 - $54,258	6,406 Added 10.07%	70,035 $536,000
Q2 2017 Aug 14, 2017	BUY	N/A	63,629	63,629 $452,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account